Inappropriate Use of Medication by Elderly, Polymedicated, or Multipathological Patients with Chronic Diseases

Abstract

The growth of the aging population leads to the increase of chronic diseases, of the burden of multimorbility, and of the complexity polypharmacy. The prevalence of medication errors rises in patients with polypharmacy in primary care, and this is a major concern to healthcare systems. This study reviews the published literature on the inappropriate use of medicines in order to articulate recommendations on how to reduce it in chronic patients, particularly in those who are elderly, polymedicated, or multipathological. A systematic review of articles published from January 2000 to October 2015 was performed using MEDLINE, EMBASE, PsychInfo, Scopus, The Cochrane Library, and Index Medicus databases. We selected 80 studies in order to analyse the content that addressed the question under consideration. Our literature review found that half of patients know what their prescribed treatment is; that most of elderly people take five or more medications a day; that in elderly, polymedicated people, the probability of a medication error occurring is higher; that new tools have been recently developed to reduce errors; that elderly patients can understand written information but the presentation and format is an important factor; and that a high percentage of patients have remaining doubts after their visit. Thus, strategies based on the evidence should be applied in order to reduce medication errors.

Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy

“…The incidence of SCARs in patients treated with allopurinol has been reported to be 0.69 (95% CI 0.52, 0.92) per 1000 person-years [48]. The incidence of SJS and TEN is estimated 1.0-6.0 per million and 0.4-1.2 per million, respectively, while the incidence of DRESS is still unclear, with an estimated overall population risk between 1 in 1000 and 1 in 10,000 drug exposures [60,61].…”

Integrating functional ageing into daily clinical practice

“…The usual consequence of this accumulation of diseases along the life cycle, often managed by several physicians, is the multiplication of drug prescriptions, resulting in polypharmacy 32 . In patients with polypharmacy, there is increased uncertainty regarding cure, as well as potential for drug interferences and adverse drug reactions 33 , which impact the economic cost of disease. Indeed, in patients with multiple chronic conditions, these conditions may interact such that the patient's healthcare costs will be greater than the sum of the costs of the individual diseases 34 .…”

Safe and sound: applying quality use of medicines to high‐risk medicines

“…We are moving into a new era of biological, genomic and highly complex therapies that could offer enormous health benefits. However, knowing when and how to treat people, and balancing benefits and risks, is becoming more complex in the face of an aging population, increasing multimorbidity and the rise of polypharmacy and hyperpolypharmacy …”